Healthcare providers should offer risk-reducing medications such as tamoxifen, raloxifene and aromatase inhibitors to women at an increased risk of breast cancer or low risk of experiencing adverse effects, according to the U.S. Preventive Services Task Force (USPSTF).

The American Association of Physicists in Medicine (AAPM) has published an open letter explaining its recent decision to recommend against patient gonadal and fetal shielding during x-ray examinations.

The U.S. Preventive Services Task Force (USPSTF) has updated its screening recommendations related to screening, genetic counseling and testing for BRCA-related cancers.

The Royal Australian and New Zealand College of Radiologists (RANZCR) has published new guidelines on the ethical application of AI in healthcare.

The American College of Radiology (ACR) has developed a new guidance document on the use of prostate MRI for working up suspected or known malignancies.

The U.S. Nuclear Regulatory Commission (NRC) has proposed a new revision to its guidance document designed for patients to read before and after they have been administered radioactive material.

The American Society for Radiation Oncology (ASTRO) has created new guidelines on the use of radiation therapy to treat pancreatic cancer patients.

The American College of Radiology (ACR) has cheered the inclusion of a key provision to the No Surprises Act (HR 3630), new legislation designed to address the issue of surprise medical bills.